Gerard Roch Alba
Institutions of which they are part
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Gerard Roch Alba

Institutions of which they are part
Neurodegenerative Diseases
The initiative seeks to raise awareness of the disease and promote the well-being of those affected, while fostering empathy and scientific vocations among young people.
On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.
Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy.
We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.